🚀 VC round data is live in beta, check it out!
Carasent Valuation Multiples
Discover revenue and EBITDA valuation multiples for Carasent and similar public comparables like Kanamic Network, Ever Fortune.AI, Airdoc, Kusurinomadoguchi and more.
Carasent Overview
About Carasent
Carasent AB (publ) Formerly Carasent AB is in the businesses that develop entrepreneurial and e-health solutions. It delivers cloud based EHR solutions, with Webdoc as the platform, and a ecosystem of platform services, including solutions for patient communication and business intelligence. The ecosystem of solutions makes Carasent a one-stop shop for clinics and can cover all needs.
Founded
1997
HQ
Employees
165
Website
Financials (LTM)
EV
$160M
Carasent Financials
Carasent reported last 12-month revenue of $39M and EBITDA of $9M.
In the same LTM period, Carasent generated $33M in gross profit, $9M in EBITDA, and $4M in net income.
Revenue (LTM)
Carasent P&L
In the most recent fiscal year, Carasent reported revenue of $39M and EBITDA of $11M.
Carasent expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $39M | XXX | $39M | XXX | XXX | XXX |
| Gross Profit | $33M | XXX | $32M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 82% | XXX | XXX | XXX |
| EBITDA | $9M | XXX | $11M | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $4M | XXX | $4M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Carasent Stock Performance
Carasent has current market cap of $171M, and enterprise value of $160M.
Market Cap Evolution
Carasent's stock price is $2.56.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $160M | $171M | 0.3% | XXX | XXX | XXX | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCarasent Valuation Multiples
Carasent trades at 4.1x EV/Revenue multiple, and 17.9x EV/EBITDA.
EV / Revenue (LTM)
Carasent Financial Valuation Multiples
As of April 20, 2026, Carasent has market cap of $171M and EV of $160M.
Equity research analysts estimate Carasent's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carasent has a P/E ratio of 45.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $171M | XXX | $171M | XXX | XXX | XXX |
| EV (current) | $160M | XXX | $160M | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | 17.9x | XXX | 15.2x | XXX | XXX | XXX |
| EV/EBIT | 82.9x | XXX | 143.8x | XXX | XXX | XXX |
| EV/Gross Profit | 4.8x | XXX | 5.1x | XXX | XXX | XXX |
| P/E | 45.3x | XXX | 43.9x | XXX | XXX | XXX |
| EV/FCF | 137.6x | XXX | (3081.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Carasent Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Carasent Margins & Growth Rates
Carasent's revenue in the last 12 month grew by 9%.
Carasent's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Carasent's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carasent's rule of X is 51% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Carasent Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | 0% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 51% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 79% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Carasent Public Comps
See public comps and valuation multiples for other Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Carasent | XXX | XXX | XXX | XXX | XXX | XXX |
| Kanamic Network | XXX | XXX | XXX | XXX | XXX | XXX |
| Ever Fortune.AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Airdoc | XXX | XXX | XXX | XXX | XXX | XXX |
| Kusurinomadoguchi | XXX | XXX | XXX | XXX | XXX | XXX |
| Nano X Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carasent M&A Activity
Carasent acquired XXX companies to date.
Last acquisition by Carasent was on XXXXXXXX, XXXXX. Carasent acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Carasent
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCarasent Investment Activity
Carasent invested in XXX companies to date.
Carasent made its latest investment on XXXXXXXX, XXXXX. Carasent invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Carasent
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Carasent
| When was Carasent founded? | Carasent was founded in 1997. |
| Where is Carasent headquartered? | Carasent is headquartered in Norway. |
| How many employees does Carasent have? | As of today, Carasent has over 165 employees. |
| Who is the CEO of Carasent? | Carasent's CEO is Daniel Ohman. |
| Is Carasent publicly listed? | Yes, Carasent is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Carasent? | Carasent trades under CARA ticker. |
| When did Carasent go public? | Carasent went public in 2012. |
| Who are competitors of Carasent? | Carasent main competitors are Kanamic Network, Ever Fortune.AI, Airdoc, Kusurinomadoguchi. |
| What is the current market cap of Carasent? | Carasent's current market cap is $171M. |
| What is the current revenue of Carasent? | Carasent's last 12 months revenue is $39M. |
| What is the current revenue growth of Carasent? | Carasent revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Carasent? | Current revenue multiple of Carasent is 4.1x. |
| Is Carasent profitable? | Yes, Carasent is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Carasent? | Carasent's last 12 months EBITDA is $9M. |
| What is Carasent's EBITDA margin? | Carasent's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Carasent? | Current EBITDA multiple of Carasent is 17.9x. |
| What is the current FCF of Carasent? | Carasent's last 12 months FCF is $1M. |
| What is Carasent's FCF margin? | Carasent's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Carasent? | Current FCF multiple of Carasent is 137.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.